Filters
Patients who recovered from COVID-19 harbour SARS-CoV-2-specific T cells as shown in a Singapore study. This, the scientists suggest, bodes well for the development of long-term protective immunity against the coronavirus.
Deep vein thrombosis (DVT) appears to be common in patients with the coronavirus disease 2019 (COVID-19) and is associated with worse outcomes, a new study has found.
The survival benefits associated with treating hepatitis C virus (HCV) infections are driven primarily by a reduction in liver-related mortality, a recent study has found.
Among patients with COVID-19, acute myocardial injury occurs commonly, especially in the elderly with pre-existing cardiovascular disease, and is tied to poor prognosis, a study has found.
Among COVID-19 patients without severe chronic liver disease, liver abnormalities seen during infection are usually mild and tend to resolve over time, as reported in a study. These alterations are tied to increased risk of ICU admission but not death.
Exposure to coronaviruses appears to trigger a stable and multispecific T cell immune response to the structural nucleocapsid protein (NP), according to a recent study.
Patients with myocardial infarction (MI) are experiencing delayed presentation to hospital, delayed treatment, and worse clinical outcomes during the coronavirus disease 2019 (COVID-19) pandemic, a study at Queen Mary Hospital (QMH) in Hong Kong has reported.
Oral antithrombotic therapies do not seem to confer survival benefits in nursing home residents with the coronavirus disease 2019 (COVID-19), a new study has shown.
Convalescent plasma therapy does not appear to improve clinical outcomes or mortality in patients with severe or life-threatening COVID-19, according to a study from China.
Use of intravenous antibiotics is sufficient to treat children with ventriculoperitoneal (VP) shunt infections, particularly those infected by Gram-negative organisms and with cerebrospinal fluid (CSF) glucose level of >40 mg/dl, suggests an Iran study.
